anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

178,321-178,380 of 319,975

filter-aware
72
The slide uses a combination of a bubble chart for markets, a process/matrix diagram for product generations, and a waterfall-style chart for value creation.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
73
Uses a custom mapping framework to link operational inputs to value outcomes.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
74
The slide uses a color-coded row system to categorize different product lines.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
75
Includes specific R&D targets and sustainability metrics.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
76
Includes a timeline-style product innovation path and market growth projections.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
77
Includes a bar chart showing reduction of off-flavor compounds via gene editing and a timeline for product generations.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
78
Includes a product innovation path timeline and market growth metrics.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
79
The slide uses a combination of market sizing, product value proposition, and a timeline-based innovation roadmap.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
80
Benson Hill | Investor Day Presentation Deck | 82 slidesBenson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
81
Benson Hill | Investor Day Presentation Deck | 82 slidesBenson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
82
The slide presents two side-by-side reconciliation tables for financial metrics.Benson Hill | Investor Day Presentation Deck | 82 slides · Benson Hill
Conference presentation Investor relations 1 hit
01
Slide 1
Includes ticker symbols and date.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
02
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
03
Uses a vertical timeline-style list to present company highlights.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a standard pharmaceutical pipeline table format.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
05
The slide uses a biological process diagram to explain allosteric modulation and a conceptual graph to illustrate how NAMs and PAMs restore normal activity.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
06
Uses a biological mechanism diagram to contrast normal vs. disease states and the therapeutic intervention.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
07
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
08
The chart uses a funnel-like visualization to show the narrowing of the target population from total prevalence to the specific opportunity for BNC210.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide uses a bar chart to visualize efficacy data from a small-scale human study.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
10
Includes fMRI and behavioral task data from a 4-way crossover study.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
11
The slide uses a flywheel diagram to illustrate the benefits of BNC210 and a comparison table to validate the competitive advantage.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
12
Includes a pharmacokinetic chart showing concentration vs time for different doses.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · Why Now1 hit
13
The slide uses a process flow diagram to illustrate the clinical trial design.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
14
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
15
The slide uses a funnel-like visual to represent the patient population and market opportunity.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
16
The slide uses a before-after-bridge style structure to connect the problem (anxiety/PTSD) to the solution (BNC210) via experimental evidence.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
17
The slide uses a process flow diagram to show the evolution of the drug development program.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
18
The slide uses a combination of exposure-response modeling and pharmacokinetic data to validate the new formulation.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
19
The slide outlines a 12-week outpatient BID dosing period followed by a follow-up phase, with specific primary and secondary endpoints.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
20
The slide features a stylized icon of a human head containing a group of people and a microscope, overlaid with a network/process graphic.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
21
The slide highlights a specific partnership with Merck, detailing financial milestones and clinical progress, supported by bar charts showing efficacy in animal models.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
22
The slide uses a newspaper graphic to frame the announcement as a significant news event.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
23
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
24
Includes images of ASX and Nasdaq listing displays.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
25
The slide uses a vertical timeline-like structure to present key strategic pillars.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
26
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
27
The slide uses a combination of headshots for the management team and a list format for the board of directors, accompanied by a grid of corporate logos.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
28
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
29
The central hub describes the drug mechanism, while the four quadrants detail specific symptom clusters and corresponding evidence.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
30
The table provides a comprehensive overview of clinical trial progress across multiple phases and indications.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
31
The slide uses a combination of a line chart showing dose-response reduction and a process flow diagram to explain the mechanism of action.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
32
The slide uses a structured table layout to define the clinical trial parameters.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
33
The slide uses a mix of bullet points and a callout box for the 'reasons' section.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
34
The slide features a stylized illustration of neurons, reinforcing the CNS (Central Nervous System) theme.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
35
The chart shows reversal of PCP-induced cognitive deficits in mice, with BL-76 showing dose-dependent efficacy.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
36
The slide uses a process-flow style layout to connect genetic rationale to compound development and preclinical results.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
37
Bionomics | Investor Presentation Deck | 38 slidesBionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
38
The slide details a specific business development milestone involving a licensing deal and potential revenue streams.Bionomics | Investor Presentation Deck | 38 slides · Bionomics
Pitch deck Investor relations 1 hit
01
Slide 1
BlackRock | Results Presentation Deck | 12 slidesBlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
02
The slide uses stacked bar charts to compare AUM and Base Fees for four different categories.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
03
Includes LTM organic asset growth rate and LTM organic base fee growth rate metrics.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
04
Includes a disclaimer regarding GAAP reconciliation and definition updates for 2022.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
05
The left chart combines a bar chart for share repurchases and a line chart for weighted-average diluted shares. The right chart is a bar chart for dividends per share.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · What Is1 hit
06
Includes a footnote explaining the calculation of the BLK Equity Index.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
07
Includes a pie chart for revenue mix, a table for growth percentages, and two waterfall charts for variance analysis.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
08
The slide uses two waterfall charts to bridge revenue changes across different time periods.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
09
Includes detailed footnotes regarding adjustments to GAAP figures.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
10
Includes a memo section for liquid credit and detailed definitions of asset categories.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit
11
Includes a detailed footnote regarding methodology changes in Q1 2022.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · New Bliss1 hit